Frequent expression of the breast differentiation antigen NY-BR-1 in mammary and extramammary Paget's disease

Pathology International

Volumn 60, Issue 11, 2010, Pages 726-734

  Giger, Olivier ^a   Caduff, Rosmarie ^a   O'Meara, Alix ^b   Diener, Pierre Andre ^c   Knuth, Alexander ^a   JäGer, Dirk ^d   Moch, Holger ^a   Varga, Zsuzsanna ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b TRIEMLI HOSPITAL   (Switzerland)

^c Institute of Pathology   (Switzerland)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Apoeccrine glands; Mammary like glands; NY BR 1; Paget's disease

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 20; CYTOKERATIN 7; DIFFERENTIATION ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; NY BR 1 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PAGET NIPPLE DISEASE; PAGET SKIN DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PAGET DISEASE, EXTRAMAMMARY; PAGET'S DISEASE, MAMMARY;

EID: 77958486237     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2010.02591.x     Document Type: Article

References (38)

1. Toker C. Clear cells of the nipple epidermis. Cancer 1970; 25: 601-10.
2. Fanning J, Lambert HC, Hale TM, Morris PC, Schuerch C. Paget's disease of the vulva: Prevalence of associated vulvar adenocarcinoma, invasive Paget's disease, and recurrence after surgical excision. Am J Obstet Gynecol 1999; 180: 24-7.
3. Kohler S, Rouse RV, Smoller BR. The differential diagnosis of pagetoid cells in the epidermis. Mod Pathol 1998; 11: 79-92.
4. Marucci G, Betts CM, Golouh R, Peterse JL, Foschini MP, Eusebi V. Toker cells are probably precursors of Paget cell carcinoma: A morphological and ultrastructural description. Virchows Arch 2002; 441: 117-23.
5. Reich O, Liegl B, Tamussino K, Regauer S. p185HER2 overexpression and HER2 oncogene amplification in recurrent vulvar Paget's disease. Mod Pathol 2005; 18: 354-7.
6. Crocker H. Paget's disease affecting the scrotum and penis. Trans Pathol Soc Lond 1888; 1888-1889: 187-91.
7. Beer GM, Baumuller S, Zech N et al. Immunohistochemical differentiation and localization analysis of sweat glands in the adult human axilla. Plast Reconstr Surg 2006; 117: 2043-9.
8. Wilkinson EJ, Vulvar BHM. Paget disease of urothelial origin: A report of three cases and a proposed classification of vulvar Paget disease. Hum Pathol 2002; 33: 549-54.
9. Crawford D, Nimmo M, Clement PB et al. Prognostic factors in Paget's disease of the vulva: A study of 21 cases. Int J Gynecol Pathol 1999; 18: 351-9.
10. Mehta NJ, Torno R, Sorra T. Extramammary Paget's disease. South Med J 2000; 93: 713-5.
11. Chen YH, Wong TW, Lee JY. Depigmented genital extramammary Paget's disease: A possible histogenetic link to Toker's clear cells and clear cell papulosis. J Cutan Pathol 2001; 28: 105-8.
12. Van Der Putte SC. Anogenital 'sweat' glands. Histology and pathology of a gland that may mimic mammary glands. Am J Dermatopathol 1991; 13: 557-67.
13. Van Der Putte SC. Mammary-like glands of the vulva and their disorders. Int J Gynecol Pathol 1994; 13: 150-60.
14. Willman JH, Golitz LE, Fitzpatrick JE. Clear cells of Toker in accessory nipples. J Cutan Pathol 2003; 30: 256-60.
15. Lloyd J, Flanagan AM. Mammary and extramammary Paget's disease. J Clin Pathol 2000; 53: 742-9.
16. Jager D, Filonenko V, Gout I et al. NY-BR-1 is a differentiation antigen of the mammary gland. Appl Immunohistochem Mol Morphol 2007; 15: 77-83.
17. Varga Z, Theurillat JP, Filonenko V et al. Preferential nuclear and cytoplasmic NY-BR-1 protein expression in primary breast cancer and lymph node metastases. Clin Cancer Res 2006; 12: 2745-51.
18. Theurillat JP, Zurrer-Hardi U, Varga Z et al. Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts. Int J Cancer 2008; 122: 1585-91.
19. Giger OT, Lacoste E, Honegger C, Padberg B, Moch H, Varga Z. Expression of the breast differentiation antigen NY-BR-1 in a phyllodes tumor of the vulva. Virchows Arch 2007; 450: 471-4.
20. Jager D, Stockert E, Gure AO et al. Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library. Cancer Res 2001; 61: 2055-61.
21. Theurillat JP, Zurrer-Hardi U, Varga Z et al. NY-BR-1 protein expression in breast carcinoma: A mammary gland differentiation antigen as target for cancer immunotherapy. Cancer Immunol Immunother 2007; 56: 1723-31.
22. Wolff AC, Hammond ME, Schwartz JN et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007; 25: 118-45.
23. Anderson JM, Ariga R, Govil H et al. Assessment of Her-2/Neu status by immunohistochemistry and fluorescence in situ hybridization in mammary Paget disease and underlying carcinoma. Appl Immunohistochem Mol Morphol 2003; 11: 120-24.
24. Bianco MK, Vasef MA. HER-2 gene amplification in Paget disease of the nipple and extramammary site: A chromogenic in situ hybridization study. Diagn Mol Pathol 2006; 15: 131-5.
25. Tanskanen M, Jahkola T, Asko-Seljavaara S, Jalkanen J, Isola J. HER2 oncogene amplification in extramammary Paget's disease. Histopathology 2003; 42: 575-9.
26. Ogawa T, Nagashima Y, Wada H et al. Extramammary Paget's disease: Analysis of growth signal pathway from the human epidermal growth factor receptor 2 protein. Hum Pathol 2005; 36: 1273-80.
27. Abbott JJ, Ahmed I. Adenocarcinoma of mammary-like glands of the vulva: Report of a case and review of the literature. Am J Dermatopathol 2006; 28: 127-33.
28. Guarner J, Cohen C, DeRose PB. Histogenesis of extramammary and mammary Paget cells. An immunohistochemical study. Am J Dermatopathol 1989; 11: 313-8.
29. Jager D, Unkelbach M, Frei C et al. Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum. Cancer Immun 2002; 2: 5.
30. Brown HM, Wilkinson EJ. Uroplakin-III to distinguish primary vulvar Paget disease from Paget disease secondary to urothelial carcinoma. Hum Pathol 2002; 33: 545-8.
31. Urabe A, Matsukuma A, Shimizu N, Nishimura M, Wada H, Hori Y. Extramammary Paget's disease: Comparative histopathologic studies of intraductal carcinoma of the breast and apocrine adenocarcinoma. J Cutan Pathol 1990; 17: 257-65.
32. Lau J, Kohler S. Keratin profile of intraepidermal cells in Paget's disease, extramammary Paget's disease, and pagetoid squamous cell carcinoma in situ. J Cutan Pathol 2003; 30: 449-54.
33. Liegl B, Leibl S, Gogg-Kamerer M, Tessaro B, Horn LC, Moinfar F. Mammary and extramammary Paget's disease: An immunohistochemical study of 83 cases. Histopathology 2007; 50: 439-47.
34. Williamson JD, Colome MI, Sahin A, Ayala AG, Medeiros LJ. Pagetoid bowen disease: A report of 2 cases that express cytokeratin 7. Arch Pathol Lab Med 2000; 124: 427-30.
35. Kanitakis J. Mammary and extramammary Paget's disease. J Eur Acad Dermatol Venereol 2007; 21: 581-90.
36. Kuan SF, Montag AG, Hart J, Krausz T, Recant W. Differential expression of mucin genes in mammary and extramammary Paget's disease. Am J Surg Pathol 2001; 25: 1469-77.
37. Kinkor Z, Michal M. [Anogenital mammary type sclerosing adenosis-two case reports and the review of literature]. Ceska Gynekol 2004; 69: 292-7.
38. Nishie W, Sawamura D, Mayuzumi M, Takahashi S, Shimizu H. Hidradenoma papilliferum with mixed histopathologic features of syringocystadenoma papilliferum and anogenital mammary-like glands. J Cutan Pathol 2004; 31: 561-4.